Neurologists from multiple clinics shared data at AAIC on the Alzheimer's drug's use, shedding light on its safety and ...

The firm will retain rights to its preclinical assets including two T-cell receptor T-cell therapies and its allogenic program.

The impact of Tagrisso plus chemo on overall survival in a Phase III trial has boosted the firms' confidence to parry competitors.

The FDA investigated the death of a boy in Brazil on Elevidys and concluded it was unrelated to the treatment.

As Keytruda generic competition looms larger on the horizon, the company is hoping to reinvest the savings into pipeline growth drivers.

Trontinemab is a formulation of Roche's failed gantenerumab but now paired with the company's Brainshuttle technology to ...

The therapies, which are just starting to enter clinical trials, will need to prove clear clinical and quality-of-life ...

The FDA investigated the death of a boy in Brazil on Elevidys and concluded it was unrelated to the treatment.

The trial will test several treatment approaches in the maintenance setting for extensive stage small cell lung cancer.

NEW YORK – The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended regulators approve Servier's IDH1/2 inhibitor Voranigo (vorasidenib) as a treatment for ...

The Medicines and Healthcare Products Regulatory Agency said it will closely track adverse events associated with the treatment.